Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis

被引:322
|
作者
Reed, Caitlin [1 ]
Bryant, Richard [2 ,3 ]
Ibrahim, Ashraf S. [1 ,3 ]
Edwards, John, Jr. [1 ,3 ]
Filler, Scott G. [1 ,3 ]
Goldberg, Robert [2 ,3 ]
Spellberg, Brad [1 ,3 ]
机构
[1] Harbor UCLA Med Ctr, Div Infect Dis, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA
[2] Univ Calif Los Angeles, Med Ctr, Dept Orbital & Ophthalm Plast Surg, Los Angeles, CA 90024 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
D O I
10.1086/589857
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. It has been axiomatic that echinocandins ( e. g., caspofungin) are ineffective against mucormycosis. However, on the basis of preclinical data, we recently began treating rhino- orbital- cerebral mucormycosis ( ROCM) with combination polyene- caspofungin therapy. Methods. To determine the impact of polyene-caspofungin therapy, ROCM cases identified by an International Classification of Diseases, Ninth Revision search were retrospectively reviewed to gather data on demographic characteristics, clinical history, and outcomes. The predefined primary end point was success (i.e., the patients was alive and not in hospice care) at 30 days after hospital discharge. Results. Forty-one patients with biopsy-proven ROCM were identified over 12 years; 23 (56%) of these patients were Hispanic, and 34 (83%) were diabetic. Patients treated with polyene-caspofungin therapy (6 evaluable patients) had superior success (100% vs. 45%; P = .02) and Kaplan-Meier survival time (P = .02), compared with patients treated with polyene monotherapy. Patients treated with amphotericin B lipid complex had inferior success (37% vs. 72%; P= .03) and a higher clinical failure rate (45% vs. 21%; P = .04), compared with patients who received other polyenes. However, patients treated with amphotericin B lipid complex plus caspofungin had superior success (100% vs. 20%; P = .009) and survival time (P = .01), compared with patients who received amphotericin B lipid complex alone. The benefit of combination therapy, compared with monotherapy, was most pronounced in patients with cerebral involvement (success rate, 100% vs. 25%; P = .01). In multivariate analysis, only receipt of combination therapy was significantly associated with improved outcomes (odds ratio, 10.9; 95% confidence interval, 1.3-infinity; P = .02). Conclusions. Combination polyene-caspofungin therapy represents a promising potential alternative to polyene monotherapy for patients with ROCM. Randomized, prospective investigation of these findings is warranted.
引用
收藏
页码:364 / 371
页数:8
相关论文
共 50 条
  • [21] Rhino-Orbital-Cerebral Mucormycosis (ROCM): A Comprehensive Case Review
    DiBartolo, Michael A.
    Kelley, Patrick S.
    AVIATION SPACE AND ENVIRONMENTAL MEDICINE, 2011, 82 (09): : 913 - 916
  • [22] Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes
    Bhansali, A
    Bhadada, S
    Sharma, A
    Suresh, V
    Gupta, A
    Singh, P
    Chakarbarti, A
    Dash, RJ
    POSTGRADUATE MEDICAL JOURNAL, 2004, 80 (949) : 670 - 674
  • [23] Imaging Patterns of Rhino-Orbital-Cerebral Mucormycosis in Immunocompromised Patients
    Raab, Peter
    Sedlacek, Ludwig
    Buchholz, Stefanie
    Stolle, Stefan
    Lanfermann, H.
    CLINICAL NEURORADIOLOGY, 2017, 27 (04) : 469 - 475
  • [25] RHINO-ORBITAL-CEREBRAL MUCORMYCOSIS - A CLINICOPATHOLOGICAL REPORT OF 2 CASES
    ESAKOWITZ, L
    COOK, SD
    ADAMS, J
    DOYLE, D
    GROSSART, KWM
    MACPHERSON, P
    MCFADZEAN, RM
    SCOTTISH MEDICAL JOURNAL, 1987, 32 (06) : 180 - 182
  • [27] Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient
    Fairley, C
    Sullivan, TJ
    Bartley, P
    Allworth, T
    Lewandowski, R
    OPHTHALMOLOGY, 2000, 107 (03) : 555 - 558
  • [28] Rhino-orbital-cerebral mucormycosis with diabetic ketoacidosis: a case report
    Rodprasert, M. D. Kritsada
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S186 - S187
  • [29] Rhino-orbital-cerebral mucormycosis as a complication of coronavirus disease 2019
    Raid M Al-Ani
    World Journal of Virology, 2022, 11 (05) : 293 - 299
  • [30] Rhino-orbital-cerebral mucormycosis in type 1 diabetes mellitus
    Bhadada S.
    Bhansali A.
    Reddy K.S.S.
    Bhat R.V.
    Khandelwal N.
    Gupta A.K.
    The Indian Journal of Pediatrics, 2005, 72 (8) : 671 - 674